Raleigh-based Innovate Biopharmaceuticals, a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, has finalized its merger with Israeli-based RDD Pharma, a startup focused on orphan and innovative therapies for gastrointestinal disorders. The result: 9 Meters Biopharm
Read More
The result: a new gastroenterology-focused company called 9 Meters Biopharma (which is the approximate length of digestive tract) that will focus on specialty, rare and orphan diseases, it was announced today.
Read More
Innovate Biopharmaceuticals has reached a deal with investors to raise millions in capital as it gears up for a stage 3 clinical trial of its lead drug candidate.
Read More
The chief executive officer of Raleigh-based Innovate Biopharmaceuticals Inc. has left the company, according to a securities filing.
Read More
Raleigh-based drug development company Innovate Biopharmaceuticals Inc. reported a third quarter loss, but still came out better than analysts had predicted. Check out their performance here.
Read More
Six North Carolina bioscience companies are among 15 companies from the Southeast selected as finalists for awards to be given at the 20th annual SEBIO Investor and Partnering Forum in Atlanta next month.
Read MoreInnovate Biopharmapueticals Inc.’s chief executive officer saw a 59 percent decrease in total compensation in the company’s 2017 fiscal year due to a decrease in option awards, according to a Securities and Exchange Commission filing.
Read MoreDrug development company Innovate Biopharmaceuticals Inc. reported a second quarter loss that beat analyst estimates.
Read MoreA Raleigh-based pharmaceutical company raised $18.2 million as part of its reverse merger.
Read More
